Kalaris Therapeutics, Inc. (KLRS) Stock

NASDAQ: KLRSHealthcare company in the biotechnology industry, based in Berkeley Heights, NJ.

Kalaris Therapeutics stock price chart

KLRS interactive chart →

KLRS stock quote & key statistics

Kalaris Therapeutics earnings per share

Income →
Earnings per share

Kalaris Therapeutics revenue & net income

Income →
RevenueNet income

Kalaris Therapeutics annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$0-$43.4M-$4.21
FY2024$0-$58.8M-$4.41
FY2023$0-$14.7M-$1.83
FY2022$0-$15.5M-$2.20

Fiscal year ending December 31. Source: company filings via EODHD.

About Kalaris Therapeutics, Inc.

Kalaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for prevalent retinal diseases. It develops TH103, a clinical-stage anti-vascular endothelial growth factor (VEGF) drug for the treatment of neovascular age-related macular degeneration (nAMD), which is in Phase 1b/2, as well as for the treatment of other exudative and neovascular retinal diseases.

Kalaris Therapeutics, Inc. was formerly known as Theia Therapeutics, Inc. and changed its name to Kalaris Therapeutics, Inc. in May 2024. The company was founded in 2019 and is headquartered in Berkeley Heights, New Jersey.

Kalaris Therapeutics stock FAQ

What is the Kalaris Therapeutics stock ticker symbol?

Kalaris Therapeutics, Inc. trades on the NASDAQ under the ticker symbol KLRS.

What sector and industry is Kalaris Therapeutics in?

Kalaris Therapeutics, Inc. is classified in the Healthcare sector, Biotechnology industry.

How many employees does Kalaris Therapeutics have?

Kalaris Therapeutics, Inc. has about 20 full-time employees.

What were Kalaris Therapeutics's revenue and earnings last fiscal year?

Kalaris Therapeutics reported revenue of $0 and net income of -$43.4M in fiscal 2025, with earnings per share of -$4.21.

When did Kalaris Therapeutics go public?

Kalaris Therapeutics stock began trading on July 30, 2020.

Biotechnology stocks

All Healthcare stocks →